-
For nearly 90 years, scientists believed magnetism fell into just two categories, but researchers have now confirmed a remarkable third type called altermagnetism. Using specialized X-rays, they uncovered a unique magnetic signature that proves these materials behave differently from conventional magnets. Altermagnets combine stability with the ability to efficiently carry information, potentially overcoming major limitations in today's electronics. The discovery could lead to faster computers, more efficient data centers, and breakthroughs in quantum technology.
-
NASA is exploring a daring plan to save the legendary Hubble Space Telescope from its eventual fiery plunge into Earth's atmosphere. After more than 35 years of groundbreaking discoveries, Hubble is slowly losing altitude, and without intervention, it could fall back to Earth as early as 2033 or 2034. To keep the iconic observatory operating, NASA is asking private space companies to propose innovative ways to boost Hubble into a higher orbit, upgrade its capabilities, or safely dispose of it when its mission finally ends.
-
MIT scientists have challenged two decades of conventional thinking by discovering that flexible molecular connections, rather than rigid ones, can unlock entirely new ways to arrange nanoparticles. The breakthrough could lead to a new generation of designer materials with unusual properties and applications in electronics, medicine, and energy.
-
Scientists have discovered a compound that transforms a natural muscle-repair protein into a more powerful version dubbed "Super HGF," more than doubling its ability to bind to a key receptor while protecting it from age-related chemical damage. The breakthrough, supported by early mouse experiments, could eventually help combat muscle loss and preserve strength as people age.
-
Stanford researchers have discovered an AI-identified natural molecule that dramatically suppresses appetite and promotes fat loss in animals, potentially offering an Ozempic-like weight-loss treatment without common digestive side effects or significant muscle loss. Called BRP, the molecule reduced food intake by up to 50% and targets a different brain pathway, raising hopes for a more precise obesity treatment if future human trials prove successful.
